Riskpilot← Back to searchSign inGet full accessMADLAKLINIKKEN AS
ASActiveOrg 924446412Madlakrossen 9, 4042 HafrsfjordGeneral medical practice activities · NACE 8621Est. 20207 employees
Revenue 2024
NOK 4,9M
-1% vs 2023
EBITDA margin
2.1%
+201% vs 2023
Equity ratio
-60.7%
Financial strength
Net profit 2024
NOK 60K
+709% vs 2023
| Revenue | NOK 4,9M | -1% |
| EBITDA | NOK 104K | +201% |
| Net profit | NOK 60K | +709% |
| Total assets | NOK 408K | -3% |
| Equity | NOK -247K | +20% |
| Employees | 7 | — |
Legal name
MADLAKLINIKKEN AS
Org number
924446412
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
20. januar 2020
Share capital
NOK 30 000
Employees
7 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Drift av legesenter.
Address
Madlakrossen 9, 4042 Hafrsfjord
Phone
+4751938890
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 008 | 4 683 | 4 317 | 4 971 | 4 932 |
| Staff expenses | −2 133 | −2 353 | −2 331 | −2 503 | −2 459 |
| EBITDA | −120 | 263 | −284 | 35 | 104 |
| Depreciation & amort. | −53 | −53 | −55 | −44 | −44 |
| EBIT | −173 | 211 | −339 | −9 | 60 |
| Net financials | −8 | −3 | −2 | −0 | 0 |
| Profit before tax | −181 | 208 | −341 | −10 | 60 |
| Tax | −0 | 8 | −0 | −0 | −0 |
| Net profit | −181 | 200 | −341 | −10 | 60 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 339 | 650 | 424 | 421 | 408 |
| Equity | −157 | 43 | −297 | −307 | −247 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 496 | 607 | 721 | 729 | 655 |
| Total debt | 496 | 607 | 721 | 729 | 655 |
EBITDA margin
2.1%
This company
15.8%
Market median
-87% vs market
20202024
Equity ratio
-60.7%
This company
38.2%
Market median
-259% vs market
20202024
Return on equity
6001100.0%
This company
18.4%
Market median
+32614574% vs market
20202024
Net profit margin
1.2%
This company
8.1%
Market median
-85% vs market
20202024
Asset turnover
12.10×
This company
1.12×
Market median
+980% vs market
20202024
Debt / equity
2.65×
This company
0.62×
Market median
-327% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Board of Directors | 2020 – 2022 | |
| Chairman | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 16.67% | 16.67% | 2023 | |
| Individual | 16.67% | 16.67% | 2023 | |
| Individual | 16.67% | 16.67% | 2023 | |
| Individual | 16.67% | 16.67% | 2022 | |
| Individual | 16.67% | 16.67% | 2023 | |
| Individual | 16.67% | 16.67% | 2023 | |
| Individual | 16.67% | 16.67% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MADLAKLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sam Aiobian | Board of Directors | 0 companies |
| Anders Drabløs Bostad | Chairman | 0 companies |